Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Maverick here's NWBO's exhibitor information:
(Thanks for posting the Link!)
Name
Northwest Biotherapeutics, Inc.
Company Description
Northwest Biotherapeutics is developing DCVax® personalized dendritic cell-based therapeutic vaccines for solid tumors. The Company’s lead program is DCVax®-L treatment for glioblastoma brain cancer, for which the Company has completed a Phase III trial and has applied for product approval in the U.K. The Company has also treated a variety of other solid tumors, with encouraging results, in compassionate use cases and other clinical trials.
Website
http://www.nwbio.com
Featured Exhibitor
Yes
Product Categories (7)
Central Nervous System Tumors, Biotechnology, Clinical Trials, Immunotherapy
So tough to know what or who to believe here... Astra Zeneca's top onconolgy researcher who congratulated nwbo for its successful phase III DcVax trial, or inquirig, a 24/7 compensated troll.
They are persistent right now in trying to get shareholders to lend out shares.
There must be some event coming up where people/institutions holding short positions could get hurt.
Wow, that's a lot of extra shares in the name of market efficiency and market liquidity.
Please read one of the most frightening paragraphs
in the recent Bamboo Lounge article. It suggests that a huge number
of naked shorts (up to 2 billion?) may have infected NWBO and that the plaintiffs have
to continue their spoofing in order to keep the SP from increasing too much.
Well, its going to be ok, the science is there, and the medical community is tuned in, and patients want it.
Have faith, there is a universal truth that holds: ultimately there is justice for terminal a$$whole$.
Best Regards.
Exactly, well said.
So, the multitude of incidents detailed in NWBO's complaint against the market makers are just one big misunderstanding?
Sure kid.
________________________________
MM are not the ones bringing this down.
Always interesting to hear from Team Spoof on a Sunday.
Interesting post about Citadel possibly going public. Underwriters hate to see pending litigation gumming up IPO’s. Wouldn’t that be an irony, if Citadel was having difficulties raising capital from the financial markets. I’m sure if there were any issues NWBO could tell them “where to go”.
Shurtha, hopefully they'll build on it.
I'm thinking DCVax is a more comprehensive treatment.
The article showed that from a sample size of 3 patients, effects of this TCell derived treatment were "transient" for 2 out of the 3 patients. (But any news is good news for patients struggling with this cancer.)
Looking forward to additional DCVax information soon.
Regards.
Nemee, Sweet of you to show up at the last minute to save us all!
Your team is not getting very good press coverage today:
Denial of the Motion to Dismiss in Northwest Biotherapeutics Lawsuit Against Seven Wall Street Market Makers for Spoofing Would be a Major Catalyst for the Company
https://smithonstocks.com/denial-of-the-motion-to-dismiss-in-northwest-biotherapeutics-lawsuit-against-seven-wall-street-market-makers-for-spoofing-would-be-a-major-catalyst-for-the-company/
________________________________________________________________________
No one can say that I did not at least try to help investors here, but, we are all grownups.
Cautionary Advice can can only be given so many times , I suppose ☝️🤷🏻♂️🇬🇧
Fluteman:
More information in today's Guardian
https://amp.theguardian.com/society/2024/mar/08/sussex-man-doing-well-a-year-and-a-half-after-new-brain-cancer-treatment
Hb, you beat me by a minute. Good DD.
Have a nice weekend.
Regards.
Financial Times discussing Northwest's litigation in today's edition.
https://www.ft.com/content/4fe0f032-07e5-41d7-ac85-cceb252129a3
Worth reading. (As if the world doesn't already realize what a cesspool Wall Street is.)
AE, try this, looks like the opening remarks. Regards.
https://www.parallelparliament.co.uk/debate/2024-02-28/commons/commons-chamber/brain-tumours
AE, try this, looks like the opening remarks. Regards.
https://www.parallelparliament.co.uk/debate/2024-02-28/commons/commons-chamber/brain-tumours
Muee, there is no need to bother with the people lobbing fud and smoke bombs from their off-shore bunkers at this late date.
The DCVax die has been cast; the MAA has been submitted. There is nothing at this point the negative posters can dish up or rehash to derail the assessment process. Should be an exciting couple of months.
Regards.
Smitty, I would expect the CEO to have a pretty firm grasp on the value potential of the company, if she didn't, I wouldn't want her there. I trust her to know value. Powers is not new this industry, far from it:
Ms. Powers has served as the Chairman of NW Bio since 2007, and as CEO since 2011. Ms. Powers previously served as a Managing Director of Toucan Capital Fund II, an investment fund focused on regenerative medicine and immune therapies, from 2001 to 2010. In addition, she has over 15 years’ experience in corporate finance and restructurings, mergers and acquisitions, joint ventures and intellectual property licensing. Ms. Powers has served for many years on a number of boards and commissions, including M2GEN (an affiliate of Moffitt Cancer Center), the Chinese Biopharmaceutical Association, the Rosalind Franklin Society, the Maryland Stem Cell Research Commission, a Steering Committee of the National Academy of Sciences evaluating government research funding, and three Governors’ commissions focused on building biotech and other industries. Ms. Powers taught for more than six years at the National Institutes of Health, on medical product development and commercialization, and at Georgetown Law School as an adjunct professor. Ms. Powers serves on the boards of a number of private biotechnology companies. Ms. Powers holds a B.A. from Princeton University, magna cum laude, and a J.D. from Harvard Law School, magna cum laude.
Regards.
(Sorry about the shameless plug for Princeton)
You can't worry about these characters lobbing fud and smoke bombs from their off-shore bunkers.
Alea iacta est; The die is cast, they'll have zero effect.
Regards.
sure kid.
Red, Thanks for posting. Thought this was telling:
We are taking significant steps to assess applications for medicines approvals within statutory timeframes. We will always prioritise applications according to public health need.
Crash, I hope a significant consideration going forward is the preservation of audit rights against the defendants, keeping certain "market maker" activities in check.
Thanks for that 17 year old update.
"So Smitty if the share place has been beaten down, because of insiders loaning their enormous number of shares that are shorted..."
AP, After all the years of LP begging shareholders to "lockup" their shares, I doubt this would happen. Regards.
One wonders how many billions they received by engaging in those practices.
TS,
Your numbers look low to me. You seem to be limiting your projections to newly diagnosed GBM.
DCVax, if approved, will also be approved for recurrent GBM -- 90 % of patients have a recurrence within two years under current SOC. Also, GBM is but 30% of the brain cancers diagnosed in the UK each year. Hard to believe DCVax wouldn't quickly be approved for those other brain cancers as well.
A recent DCVax discussion assumed a 50% usage rate for GBM cancer - maybe that is accurate, yet, I'm not sure what else patients would turn to. So, I think DCVax will quickly become a highly sought treatment for most Brain cancers. Tough to understand your pessimism.
I hope you never get GBM, but if so, I genuinely hope DCVax is available to you, not that I would expect a positive outcome to change your mind about DCVax. Something about "it's difficult to get someone to believe in something when his salary depends on him not believing it."
Regards.
Really? A 95% probability of approval DCVax-L by MHRA in the UK, according to Larry Smith (Smith on Stocks) and there's nothing to talk about??? Hmm, if you read his analysis -assuming you hold a long position- I'm sure you'll feel much better about your investment (Highly Probable UK Approval of DCVax-L in 1H, 2024 Would Be a Crowning Achievement for Northwest Biotherapeutics. Jan 10, 2024.)
There's a lot in there: efficacy, virtually no side effects, manufacturing capabilities, and it being a treatment that "holds the promise for meaningful effectiveness in all resectable solid tumors" (Smith Highly Probable UK Approval of DCVax-L 1/10/2024 pg.2)
It seems there's much to like about DCVax, and much to consider, no? I don't understand your persistent negativity.
Regards.
Exactly right Doc, it's not as if investors don't realize the share price is manipulated and artificially depressed, so as a result investors don't react negatively to this continued nonsense. They are used to it by now and will wait it out until market forces are somewhat restored and price represents a reasonable value.
Thanks for posting.
GG - Perhaps, but globally it seems there is a lot of pressure to rein in the excesses and illegalities of short sellers & market makers. That could catch on here. Consensus (among investors at least) is that it is too easy to be robbed and regulators are not protecting investors (naked shorting, FTD's, dark pools, spoofing, etc.) The U.S. public is becoming more aware. Market makers ability to shut down virtually any company it chooses (let alone one with a viable cancer treatment) is not sitting well with many. Now, If nothing becomes of nwbo's litigation, I will concede US market makers are bullet proof, but in as much as the magistrate's recommendation was to grant nwbo "leave to amend" its pleading, I believe discovery will go forward and changes will result from it. Hope so, Regards.
Highly Probable UK Approval of DCVax-L in 1H, 2024 Would Be a Crowning Achievement for Northwest Biotherapeutics
Posted by Larry Smith on Jan 10, 2024
Pertinent part: Smith believes NWBO's litigation will proceed, and discovery will yield a "roadmap" to what he believes to be "one of the largest criminal enterprises on earth."
Here's to that day...
Horse, assuming litigation settlement, it will be interesting to see what audit rights NWBO will insist upon, especially given transaction records are much easier to obtain from the OTC than the from "regular" exchanges.
Regards.
No, he is not your twin.
Bruce, Smith on Stocks recently assessed a 95% probability of approval for DCVax-L in the United Kingdom. (see Smith on Stocks January 10,2024)
Nonsense is all they have left.
Regards.
Bullworth, you just can't parachute in here with the rest of your special forces and expect long term investors to buy into your act.
Not exactly news that nwbo is a pre-revenue company. Despite your efforts, no one seems to be panic selling; unfortunately, you're dealing with people who know what they hold.
Try Yahoo.
Thank god you showed up in the last 24 hours to save us all!
Gumworks, seems you're a long ways from home, who sent you?
__________________________________________________
Next Step Reverse Split?
Senti, I was able to access the Magistrate's decision with the link in your post.
Thank you for posting.
Ah... behold the market efficiencies of "algorithmic collusion" to improve the fleecing of investors. The DOJ/SEC should really step in here.
The Court also provides in footnote 28 that the “financial literature suggests another reason why Defendants did not need to coordinate a spoofing scheme: their algorithmic trading programs can do it for them. A recent study found that algorithms can ‘learn to coordinate their spoofing when they learn together,’ even without human intervention. This is known as “algorithmic collusion.” (Page 64 - https://www.pacermonitor.com/view/DK3H7KQ/Northwest_Biotherapeutics_Inc_v_Canaccord_Genuity_LLC_et_al__nysdce-22-10185__0137.0.pdf)
This is why we will never give into the soulless ghouls who are trying to delay & destroy nwbo to feed their personal coffers.
https://www.msn.com/en-us/health/other/terminally-ill-connecticut-woman-ends-her-life-on-her-own-terms-in-vermont/ar-AA1mtKij?ocid=msedgntp&pc=LSJS&cvid=b198a986067f43c3bc0b30fedc998c3e&ei=12
Zadie, This may be a minority view, but once LP was advised the MAA application was lacking in some area(s), didn't it make sense to correct the application prior to submittal? I can't imagine anyone, let alone someone charged with a fiduciary duty, would say, we have a timeline to meet, let's just submit "as is" and see what happens. And, I can't imagine the howls she would receive if she failed to correct this. I'm glad she took the time to get the application right.
Regards.
Sounds correct.
Thanks.